WHO ICTRP trial

iDx Lung Health – Developing new tests for the early detection of lung cancer

ISRCTN39678730 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN39678730
Public title iDx Lung Health – Developing new tests for the early detection of lung cancer
Scientific title Lung health checks in Wessex and Yorkshire: integrated biomarker studies
Primary sponsor University Hospital Southampton NHS Foundation Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries United Kingdom;England
Conditions Early detection of lung cancer Cancer Malignant neoplasm of bronchus and lung
Interventions This is a prospective cohort study for the collection of blood for autoantibody, protein and nucleic acid biomarkers, and nasal epithelium for transcriptomic analysis from individuals attending for lung health checks at mobile scanners in…
Registration date Mar 2, 2021
Target size 7000
Secondary IDs Nil known;Nil known;Nil known
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations